TMCnet - World's Largest Communications and Technology Community



Research and Markets: Acute Pain - Pipeline Review, H1 2014
[June 11, 2014]

Research and Markets: Acute Pain - Pipeline Review, H1 2014

DUBLIN --(Business Wire)--

Research and Markets ( has announced the addition of the "Acute Pain - Pipeline Review, H1 2014" report to their offering.

This report provides comprehensive information on the therapeutic development for Acute Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Acute Pain and special features on late-stage and discontinued projects.

Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set ofinformation. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


  • The report provides a snapshot of the global therapeutic landscape of Acute Pain
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Acute Pain and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects

Companies Mentioned:

  • Nektar Therapeutics
  • Santen Pharmaceutical Co., Ltd.
  • Pacira Pharmaceuticals, Inc.
  • AcelRx Pharmaceuticals, Inc.
  • Laboratorios Del Dr. Esteve S.A.
  • Pfizer Inc.
  • Sigma-Tau S.p.A.
  • A. Menarini Industrie Farmaceutiche Riunite Srl
  • Anavex Life Sciences Corp.
  • Nuvo Research Inc.
  • Zalicus Inc.
  • Yungjin Pharm Ind. Co., Ltd.
  • Array BioPharma Inc.
  • Orexo AB
  • Insys Therapeutics, Inc.
  • Grunenthal GmbH
  • AngioChem Inc.
  • Charleston Laboratories, Inc.
  • Trevena, Inc.
  • Syntrix Biosystems, Inc.
  • Kineta, Inc.
  • QRxPharma Limited
  • Cara Therapeutics, Inc.
  • Iroko Pharmaceuticals, LLC
  • Encore Therapeutics Inc.
  • Madeira Therapeutics

For more information visit

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy